Beyond timing: integrating circadian biology into personalized drug therapy

Circadian rhythms are endogenous 24-hour biological cycles that regulate physiological processes and influence drug pharmacokinetics, efficacy, and safety. These rhythms modulate receptor sensitivity, enzymatic activity, and transport mechanisms, contributing to variability in therapeutic outcomes and highlighting their importance in personalized medicine. This study examines the mechanisms by which circadian rhythms affect drug responses and evaluates the potential of aligning drug administration with biological timing to optimize treatment effectiveness and minimize adverse effects. A narrative synthesis of the literature was conducted, integrating molecular, physiological, and clinical evidence in chronopharmacology. The findings indicate significant circadian variation in drug metabolism and toxicity, driven by fluctuations in cytochrome P450 enzymes, transport proteins, and immune responses. Chronotherapy has demonstrated clinical benefits in cancer treatment, blood pressure regulation, and immunosuppressive therapy. However, circadian disruption, particularly due to sleep disturbances, may impair drug efficacy and increase the risk of adverse effects. Integrating chronobiology into clinical practice, supported by wearable technologies and pharmacogenomics, offers a promising approach for optimizing individualized treatment strategies. These findings support the advancement of precision medicine through biologically timed therapeutic interventions.